DDIS-35. RelA-ACTIVITY IS ESSENTIAL FOR CANNABIDIOL-MEDIATED CYTOTOXICITY IN AN IDENTIFIED SUBSET OF GLIOBLASTOMA

Glioblastoma (GBM) therapy could strongly profit from simplified procedures for personalized medicine. Cannabidiol (CBD) is explored for GBM-patients, but the mode of drug-action is largely unknown and stratification markers are missing. We investigated CBD-induced cytotoxicity in a panel of human p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Volmar, Marie, Nagl, Bernhard, Haug, Alisha, Richter, Sven, Alenezi, Haithanm, Herold-Mende, Christel, Lamszus, Katrin, Synowitz, Michael, Schick, Joel, Kälin, Roland, Glass, Rainer
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Drug Discovery
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846907/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.286
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars